Medisca Inc.: Drug Recall
Recall #D-0570-2024 · 06/26/2024
Class II: Risk
Recall Details
- Recall Number
- D-0570-2024
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Medisca Inc.
- Status
- Completed
- Date Initiated
- 06/26/2024
- Location
- Irving, TX, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 113 bottles
Reason for Recall
CGMP Deviations and Presence of Particulate Matter: Glass
Product Description
Budesonide, USP (Micronized), 500 mg, White to off-white odorless, crystalline powder, Medisca Inc., Plattsburgh, NY, 12901, USA, NDC: 38779-3097-00.
Distribution Pattern
Nationwide in the USA and Canada
Other Recalls by Medisca Inc.
- Class II: Risk 03/31/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.